Register here to receive a copy of our report

Which European city truly offers the best 5G experience? And what sets it apart?

Speed is not everything. While fast download rates make headlines, real-world customer experience is shaped by many other factors. In the 5G era, network reliability, service consistency, and content delivery performance are just as—if not more—important than raw throughput or simple latency measurements against test servers.

This report, linked to our latest blog post "All 5G networks are not created equal: Unveiling the TRUE QoE of 5G in Europe (III)" provides an in-depth analysis of Brussels' 5G networks, highlighting:

• ✅ Comprehensive 5G performance insights and true QoE KPIs for 15 major European cities.
• 🏆 Mobile Experience Awards recognizing the best-performing and most reliable European cities.
• 📊 Performance breakdowns for accessibility, time-to-content, and value-for-speed across regular end-user activities like web browsing, social media, and gaming.
• 📡 Insights into 5G deployments, network availability, and overall 5G service experience.

Our field-based 5G benchmarking reveals clear disparities in network experience, with some operators delivering on 5G expectations while others fall short.

Upon approval of your request, you will receive a confirmation email with a secure download link. Please note that a valid work email address is required to access the report. If your request is incomplete, we may ask you to review and update your details accordingly.

MedUX is committed to recurring 5G benchmarking campaigns and is actively working towards enabling continuous, 24/7 QoE monitoring in select geographies on demand. If you are interested in exclusive insights or strategic collaborations, feel free to reach out to us at hello@medux.com.

Meanwhile, we invite you to explore the details of our recent Blog Post and download a copy of our detailed report about 5G Experience in Brussels: "Brussels´5G Falling Behind: A Wake-Up Call for Belgium´s Connectivity Strategy". 

ALL RIGHTS RESERVED. This article or report has been prepared for the exclusive use and benefit of press media and solely for non-commercial purposes. Press media members are authorized to entirely or partially disseminate, refer, quote, copy, reproduce, distribute, publish and transfer the report and its findings (including all intellectual property rights, data, content graphs and analysis) for information purposes with express attribution to MedUX. Use of the report and its findings, entirely or partially, in any form or by any means, by any other third party or for any other purposes (including, commercial or marketing purposes), without the prior written consent of MedUX, is strictly prohibited. Operators can make a request to MedUX for a license to use quality or certification seals, as well as marketing rights to quote the findings. Non-authorized use will be considered a violation of copyright and trademarks laws.